Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/19292
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChatterjee, J-
dc.contributor.authorDai, W-
dc.contributor.authorAbd Aziz, NH-
dc.contributor.authorTeo, PY-
dc.contributor.authorWahba, J-
dc.contributor.authorPhelps, DL-
dc.contributor.authorMaine, CJ-
dc.contributor.authorWhilding, L-
dc.contributor.authorDina, R-
dc.contributor.authorTrevisan, G-
dc.contributor.authorFlower, KJ-
dc.contributor.authorGeorge, AJT-
dc.contributor.authorGhaem-Maghami, S-
dc.date.accessioned2019-10-14T10:36:22Z-
dc.date.available2016-12-16-
dc.date.available2019-10-14T10:36:22Z-
dc.date.issued2016-12-16-
dc.identifier.citationClinical Cancer Research, 2017, 23 (13), pp. 3453 - 3460 (8)en_US
dc.identifier.issn1078-0432-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/19292-
dc.description.sponsorshipFunding was received from Mann-Hodgson charitable trust and Rosie's charity.en_US
dc.format.extent3453 - 3460 (8)-
dc.language.isoenen_US
dc.subjectPD1en_US
dc.subjectPDL1en_US
dc.subjectovarian cancer biomarkersen_US
dc.titleClinical use of programmed cell death-1 (PD-1) and its ligand (PD-L1) expression as discriminatory and predictive markers in ovarian canceren_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1158/1078-0432.CCR-16-2366-
dc.relation.isPartOfClinical Cancer Research-
pubs.issue13-
pubs.publication-statusPublished online-
pubs.volume23-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf832.5 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.